Supernus Pharmaceuticals, Inc.401(k)
SUPERNUS PHARMACEUTICALS, INC. 401(K) PROFIT SHARING PLAN · ROCKVILLE, MD · plan year 2025
Peer grade: B+ · admin costs + employer contributions vs same-size plans · how grading works
Supernus Pharmaceuticals, Inc. reported $147,678 in plan administrative expenses for 2025: 0.11% of average plan assets, below the peer median. Employer contributions averaged $5,845 per active participant. This ratio covers administrative expenses reported on the plan's Schedule H only; fund-level expense ratios are not included in public structured data — see methodology.
Across the 3 years on file its reported administrative ratio fell from 0.21% to 0.11%. The plan sits in the $50M–$250M size bracket, benchmarked here against 605 comparable plans and shown alongside other professional & technical services employers. By assets it is the 121st-largest of 1,671 plans among Maryland employers on file, and the 1,053rd of 11,654 in professional & technical services. In 2025, employees put in $2.22 for every $1.00 the employer contributed; active participation has grown from 614 to 789 since 2022.
Supernus Pharmaceuticals, Inc.'s 2025 employer contribution ran above the $4,093 median for plans its size. Filings report dollars actually contributed, not the match formula; the formula itself (for example, 50% of the first 6% of pay) lives in the plan's summary plan description from HR.
Annual cost at the plan's reported 2025 administrative ratio, against the median plan its size; fund expense ratios are extra. Compare any plan.
Compensation shown is direct payments from plan assets reported on Schedule C. Providers paid through fund revenue-sharing appear as indirect.
Why are you looking at this plan?
Source: U.S. Department of Labor, Form 5500 series, EIN 202590184 · Verify on EFAST2 · Amounts are as reported by the plan sponsor for the plan year shown.